Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 247-825-4 | CAS number: 26586-02-7
Endpoint summary
Administrative data
Key value for chemical safety assessment
Additional information
IN VITRO
In a reverse gene mutation assay in bacteria (BASF, 1992), strains TA 1535, TA 1537, TA 98 and TA 100 of S. typhimurium were exposed to C5 acetate (purity 98.8%; solvent: DMSO) at concentrations of up to 5000 µg/plate in the presence and absence of mammalian metabolic activation (Standard Plate test: 4-5000 µg/plate; Preincubation Test: 4-1000 µg/plate; Liquid suspension Assay: 4-1250 µg/plate).
C5 acetate was tested up to cytotoxic concentrations. There was no evidence of mutagenicity in any tester strain in the Standard Plate test with and without metabolic activation; in any tester strain in the Preincubation Test with and without metabolic activation; in any tester strain in the Liquid Suspension Assay with metabolic activation; and in tester strains TA 1535 and TA1537 in the Liquid Suspension Assay without metabolic activation. Controversial results were observed in the Liquid Suspension Assay without metabolic activation for TA 98 (slightly enhanced figures at 500 - 1000 µg/plate; factor 1.8-2.0; this could not be confirmed by a second experiment). Positive reaction was observed in the Liquid Suspension Assay without metabolic activation for TA100 from about 250 µg/plate (factor 1.8) onward with an increase in the number of mutant colonies by a factor of 8.1 at 1250 µg/plate. The positive controls induced the appropriate responses in the corresponding strains. Overall, there was no evidence of induced mutant colonies over background.
This study is classified as acceptable. This study satisfies the requirement for Test Guideline OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.
IN VIVO
No data.
Short description of key information:
IN VITRO
Not mutagenic in bacteria:
- not mutagenic in the standard Ames Test (Standard Palte Test and Preincubation Test)
- mutagenic in a modified Ames Test (Liquid Suspension Assay).
IN VIVO
No data are available.
Endpoint Conclusion:
Justification for classification or non-classification
There is no need to classify C5 acetate for mutagenicity according to the Directive 67/548/EC or GHS criteria.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
